Integral Health Asset Management »

Biohaven shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.8M 650k 15.01
2025-06-30 $4.2M 300k 14.11
2025-03-31 $4.2M 175k 24.04

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Biohaven

BlackRock
Henderson Group
Stifel Financial
Suvretta Capital Management
State Street Corporation
Vanguard Group
Bellevue Group
FMR
Caption Management
Susquehanna International
Geode Capital Management
Goldman Sachs Group
Infinitum Asset Management
Stempoint Capital
Millennium Management

View all funds holding Biohaven